Summary
The purpose of this study is to examine whether the duration of treatment with phenobarbital has an impact on neurodevelopmental and epilepsy outcomes, as well as parent and family well-being, after neonatal seizures.
Conditions
Neonatal Seizures
Recruitment Status
COMPLETED
Eligibility Criteria
Inclusion Criteria:
* Neonates \<44 weeks corrected age at seizure onset
* Seizures due to acute brain injury
* Parent(s) who are English or Spanish literate (with assistance of interpreter)
Exclusion Criteria:
* Neonates at risk for adverse outcome independent of seizures and underlying brain injury
* Neonates with mild, temporary causes for seizures
* Newborns with neonatal-onset epilepsy syndromes
* Neonates who do not survive the initial hospital admission
* Neonates will not be excluded based on race, ethnicity, gender or gestational age
Intervention
Intervention Type
Intervention Name
OTHER
Surveys
OTHER
EEG
Gender
ALL
Min Age
0 Weeks
Max Age
24 Months
Download Date
2020-12-04
Principal Investigator
N/A
Primary Contact Information
For more information on this trial, visit clinicaltrials.gov.
Contact
For more information and to contact the study team: